Jayantibh Patel
Neurology · Chandler, AZNPI 1366444341
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $429 and has fallen 88.3% since, to $50 in 2024. That places this record below the midpoint for neurology clinicians in AZ, where the typical reported total is $1,232.
Across 55 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$148
- Neurocrine Biosciences, Inc.$102
- Novartis$91
- Sunovion Pharmaceuticals Inc.$78
- Amgen$61
- Microtransponder, Inc.$50
- plus $450 from 17 others
What the payments were for
- Speaking & faculty fees$424%
- Food & beverage$92795%
- Education$111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 3 | $148 |
| Neurocrine Biosciences, Inc. | 6 | $102 |
| Novartis | 6 | $91 |
| Sunovion Pharmaceuticals Inc. | 9 | $78 |
| Amgen | 3 | $61 |
| Microtransponder, Inc. | 1 | $50 |
| Acadia Pharmaceuticals Inc | 2 | $49 |
| Acorda Therapeutics, Inc | 1 | $42 |
| UCB, Inc. | 2 | $36 |
| Biogen | 2 | $34 |
| AbbVie(2 entities) | 2 | $34 |
| SK Life Science, Inc. | 2 | $32 |
| Argenx US, Inc. | 2 | $28 |
| Travere Therapeutics, Inc. | 5 | $26 |
| GE HealthCare | 1 | $25 |
| Bristol Myers Squibb | 1 | $25 |
| Otto Bock Healthcare LP | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Neurelis, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Livanova USA, Inc. | 1 | $15 |
| Neuropace, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavenclad$124
How this compares
$980 in reported general payments places this provider in the 45th percentile of 388 neurology providers in Arizona.
Other neurology in Chandler
- Hemant PandeyChandler$230K
- Hussam Seif EddeineChandler$30K
- Marianne de LimaChandler$30K
- Barry HendinPhoenix$2.3M
- Maria OspinaPhoenix$2.1M
- Suraj MuleyPhoenix$1.7M
- Nida LaurinScottsdale$969K
- Eric ErossPhoenix$778K
- Steve ChungPhoenix$685K
- Marwan SabbaghPhoenix$603K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.